Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 11/20 | 0.40 |
| ▸ | F9 | P00740 | 5/20 | 0.40 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.34 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.34 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.34 |
| ▸ | PLAU | P00749 | 7/20 | 0.33 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.33 |
| ▸ | F2 | P00734 | 3/20 | 0.33 |
| ▸ | PLAT | P00750 | 3/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | PLG | P00747 | 2/20 | 0.32 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.32 |
| ▸ | ANO1 | Q5XXA6 | 1/20 | 0.32 |
| ▸ | HPN | P05981 | 2/20 | 0.31 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.31 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6940338 | 0.89 | F10 (0.39) | F10F9PRSS1F2THRB | |
| Hydrochloric Acid SCHEMBL7570036 | 0.88 | F10 (0.38) | F10F9PRSS1F2THRB | |
| SCHEMBL6941666 | 0.83 | F10 (0.39) | F10PRSS1F2ANO1 | |
| Hydrochloric Acid SCHEMBL7561132 | 0.82 | F10 (0.38) | F10PRSS1F2ANO1 | |
| SCHEMBL7525875 | 0.75 | F10 (0.47) | F10F9PLAUPRSS1F2 | |
| SCHEMBL2990398 | 0.74 | F7 (0.35) | F2 | |
| Hydrochloric Acid SCHEMBL7526160 | 0.74 | F10 (0.46) | F10F9PLAUPRSS1F2 | |
| SCHEMBL6942560 | 0.71 | F10 (0.37) | F10PRSS1F2ANO1 | |
| Hydrochloric Acid SCHEMBL7562752 | 0.70 | F10 (0.37) | F10PRSS1F2ANO1 | |
| SCHEMBL7528831 | 0.68 | F10 (0.46) | F10F9PLAUPRSS1F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020183519-A1 | Antithrombotic carboxylic acid amides | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2002-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020183519-A1 | Antithrombotic carboxylic acid amides | SERPINC1, TFPI, F2 | F10 33/4885F9 10/4885GABRG2 1198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.